Press Release

Joint Pain Injections Market: Coronavirus Impact – Key Takeaways

CDC reports that every year approximately 15 million people in the U.S. face severe joint pain because of arthritis. The rising prevalence of arthritis can increase the demand for treatments, which in turn, will propel the growth of the global joint pain injections market. The information is shared by Fortune Business Insights, in a report, titled “Joint Pain Injections Market Size, Share and Global Trend By Product (Corticosteroid Injections, Hyaluronic Acid Injections, Platelet-Rich Plasma Injections, Others (Placental Tissue Matrix Injections, etc), By Joint Type (Knee and Ankle

Segmentation of the Global Joint Pain Injections Market

By Product

  • Corticosteroid Injections
  • Hyaluronic Acid Injections
  • Platelet-Rich Plasma Injections
  • Others (Placental Tissue Matrix Injections, etc.)

By Joint Type

  • Knee and Ankle
  • Hip
  • Shoulder and Elbow
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Geography

  • North America (the U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Hepatitis C Testing Market

Pain Pumps Market

Chronic Lower Back Pain Treatment Market

Renal Therapeutics Market

Blood Transfusion Diagnostics Market

Ultrasonic Dissection Devices Market

Multi-Parameter Patient Monitoring Market





Antiepileptic Drugs (AED) Market

Reading Glasses Market

Hair Transplant Market

Active Pharmaceutical Ingredient Market

Opioid Use Disorder (OUD) Market

Multiple Myeloma Market

Prescription Drugs Market

Related Articles